Next Article in Journal
Assessment of Mechanical Properties of Corroded Prestressing Strands
Next Article in Special Issue
Improved Epidemic Dynamics Model and Its Prediction for COVID-19 in Italy
Previous Article in Journal
Numerical Analysis of the Influence of Empty Channels Design on Performance of Resin Flow in a Porous Plate
Previous Article in Special Issue
A Critical Analysis of Corona Related Data: What the More Reliable Data Can Imply for Western-Europe
Article

RRM Prediction of Erythrocyte Band3 Protein as Alternative Receptor for SARS-CoV-2 Virus

1
AMALNA Consulting, Black Rock, Melbourne, VIC 3193, Australia
2
College of Science, Engineering and Health, RMIT University, Melbourne, VIC 3000, Australia
3
QuantBioRes A/S - QBR A/S, 2860 Copenhagen, Denmark
*
Author to whom correspondence should be addressed.
Appl. Sci. 2020, 10(11), 4053; https://doi.org/10.3390/app10114053
Received: 10 May 2020 / Revised: 5 June 2020 / Accepted: 10 June 2020 / Published: 11 June 2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus causing a worldwide pandemic. It is infecting respiratory organs and, in more severe cases, the lungs, where it is infecting the human cells through the angiotensin-converting enzyme 2 (ACE2) receptor. In severe cases, it is characterized not only by difficulties in breathing through infected lungs, but also with disproportionally and, thus far, unexplained low levels of oxygen in the blood. Here, we propose that, besides the infection of respiratory organs through ACE2 receptors, there is an additional infection in the red blood cells (erythrocytes). There could be a possible for SARS-CoV-2 to pass through the alveoli membrane in the lungs and infect the red blood cells through another receptor. Using our own biophysical model, the Resonant Recognition Model, we propose that the red blood cell (RBC) Band3 protein on the surface of red blood cells is a possible entry point for the SARS-CoV-2 virus into red blood cells. View Full-Text
Keywords: COVID-19; SARS-CoV-2; coronavirus; ACE2; blood cells; protein–receptor interaction; resonant recognition model COVID-19; SARS-CoV-2; coronavirus; ACE2; blood cells; protein–receptor interaction; resonant recognition model
Show Figures

Figure 1

MDPI and ACS Style

Cosic, I.; Cosic, D.; Loncarevic, I. RRM Prediction of Erythrocyte Band3 Protein as Alternative Receptor for SARS-CoV-2 Virus. Appl. Sci. 2020, 10, 4053. https://doi.org/10.3390/app10114053

AMA Style

Cosic I, Cosic D, Loncarevic I. RRM Prediction of Erythrocyte Band3 Protein as Alternative Receptor for SARS-CoV-2 Virus. Applied Sciences. 2020; 10(11):4053. https://doi.org/10.3390/app10114053

Chicago/Turabian Style

Cosic, Irena, Drasko Cosic, and Ivan Loncarevic. 2020. "RRM Prediction of Erythrocyte Band3 Protein as Alternative Receptor for SARS-CoV-2 Virus" Applied Sciences 10, no. 11: 4053. https://doi.org/10.3390/app10114053

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Citations

Crossref
 
Scopus
 
Web of Science
 
Google Scholar

Article Access Statistics

Created with Highcharts 4.0.4Chart context menuArticle access statisticsFull-Text ViewsAbstract Views3. Nov4. Nov5. Nov6. Nov7. Nov8. Nov9. Nov10. Nov11. Nov12. Nov13. Nov14. Nov15. Nov16. Nov17. Nov18. Nov19. Nov20. Nov21. Nov22. Nov23. Nov24. Nov25. Nov26. Nov27. Nov28. Nov29. Nov30. Nov1. Dec2. Dec3. Dec4. Dec5. Dec6. Dec7. Dec8. Dec9. Dec10. Dec11. Dec12. Dec13. Dec14. Dec15. Dec16. Dec17. Dec18. Dec19. Dec20. Dec21. Dec22. Dec23. Dec24. Dec25. Dec26. Dec27. Dec28. Dec29. Dec30. Dec31. Dec1. Jan2. Jan3. Jan4. Jan5. Jan6. Jan7. Jan8. Jan9. Jan10. Jan11. Jan12. Jan13. Jan14. Jan15. Jan16. Jan17. Jan18. Jan19. Jan20. Jan21. Jan22. Jan23. Jan24. Jan25. Jan26. Jan27. Jan28. Jan29. Jan30. Jan31. Jan1. Feb0k1k2k3k4k5k
For more information on the journal statistics, click here.
Multiple requests from the same IP address are counted as one view.

Article Access Map by Country/Region

1
Back to TopTop